Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched the Twist TrueAmp Library Preparation Kit and Twist PCR-Free WGS Library Preparation Kit, each ...
In a recent study published in Lancet Microbe, researchers compare the potential of real-time reverse transcriptase-polymerase chain reaction (RT-PCR) genotyping assays with whole-genome sequencing ...
Correlation of polymorphisms of genes involved in platinum/gemcitabine (P/G)-based metabolism with toxicity and clinical response in patients (pts) with advanced non-small cell lung cancer (NSCLC) No ...
The global HLA typing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% during the ...
Complete the form below to access this guide to sequencing epigenetic modifications.  Epigenetics is the study of chemical ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
Influenza is a global health concern, due to annual epidemics of the disease and its potential to cause a pandemic with novel strain variants. Whole-genome sequencing enables ongoing surveillance and ...
A low DNA binding consumables range minimizes interactions between nucleic acids and plastic surfaces, supporting more ...
DNA sequence analysis software needn't be expensive. For a decade, molecular biologist Kjeld Olesen has spent much of his spare time developing pDRAW32, a free sequence-analysis software package for ...
First results of the prospective Neoadjuvant Breast Registry Symphony Trial (NBRST). This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract does not include a full text ...